Munafa Stock Market Course + Intraday & FNO calls 
GLENMARK NEWS why is Glenmark Pharmaceuticals Limited price falling or rising
GLENMARK NEWS reasons for why stock price of Glenmark Pharmaceuticals Limited is falling or rising
GLENMARK Glenmark Pharmaceuticals is falling or rising technical reasons
Technical analysis forecast of Glenmark Pharmaceuticals Stock is that its in a uptrend for shortterm, and I will avoid taking a SHORT or SELL trade in this stock. Look for opportunities to BUY or go LONG in Glenmark Pharmaceuticals GLENMARK at this time. Stock is rising and might rise more.
It appears as if Glenmark Pharmaceuticals GLENMARK gave a large move recently.
Stock of Glenmark Pharmaceuticals (GLENMARK) is trading above an important moving average line, and it has been above this line for quite some time now. This is a good sign, and the stock might keep rising and move higher!
My analysis of Glenmark Pharmaceuticals is bullish for shortterm, but trade for tomorrow is selective. Take a BUY trade only if Glenmark Pharmaceuticals stays above 2369.1, but if it comes below 2369.1, then a intra day sell could be more profitable.
If you take a sell trade below 2369.1, then use 2369.1 as stoploss and 2269.56 as target. However if you take a buy trade in Glenmark Pharmaceuticals, then use 2369.1 as stoploss and 2488.5 as target.
GLENMARK Glenmark Pharmaceuticals is falling or rising NEWS fundamental reasons
Company Announcement Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated April 09, 2026, titled "Glenmark Pharmaceuticals Receives U.S. FDA Approval for Progesterone Vaginal Inserts, 100 mg". - NEWS as on 2026-04-09
Company Announcement Glenmark Pharmaceuticals Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. - NEWS as on 2026-04-06
Company Announcement Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated April 01, 2026, titled "Glenmark Pharmaceuticals Announces Strategic Shift to Direct Commercialization and Distribution of RYALTRIS in the U.S., Significantly Expand - NEWS as on 2026-04-02
Company Announcement Glenmark Pharmaceuticals Launches GLIPIQⓇ (Semaglutide) In India. Setting a new benchmark in affordability for GLP-1 therapy, with weekly treatment starting at ₹325. - NEWS as on 2026-03-23
Company Announcement Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated March 16, 2026, titled "Glenmark Pharmaceuticals Inc., USA to launch - NEWS as on 2026-03-16
Company Announcement Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated March 04, 2026, titled "Glenmark Specialty SA Receives U.S. FDA Approval for Fluticasone Propionate Inhalation Aerosol USP, 44 mcg per actuation, with 180-Day Compet - NEWS as on 2026-03-04
Company Announcement Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated February 27, 2026, titled "Glenmark Pharmaceuticals Inc., USA to launch Sodium Phosphates Injection USP, - NEWS as on 2026-02-27
Company Announcement Glenmark Pharmaceuticals Limited has informed the Exchange about ESG Rating. - NEWS as on 2026-02-23
Company Announcement Glenmark Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication - NEWS as on 2026-02-18
Company Announcement Glenmark Pharmaceuticals Limited has informed the Exchange about Transcript - NEWS as on 2026-02-04
Company Announcement Glenmark Pharmaceuticals Limited has informed the Exchange about Schedule of meet - NEWS as on 2026-02-03
Company Announcement Glenmark Pharmaceuticals Limited has informed the Exchange about Link of Recording - NEWS as on 2026-02-02
Company Announcement Glenmark Pharmaceuticals Limited has informed the Exchange about Investor Presentation - NEWS as on 2026-02-01
More announcements and NEWS
GLENMARK Glenmark Pharmaceuticals Limited current price & indicator signals
Recent prices of GLENMARK Glenmark Pharmaceuticals Limited are as follows: Daily volume is divided by 10 day averaged volume
| Date | Close | Range | Change % | Volume |
| 30 Thu Apr 2026 | 2406.30 | 2385.60 to 2455.90 | -0.31% | 1.14 times |
| 29 Wed Apr 2026 | 2413.90 | 2403.70 to 2474.00 | 0.42% | 0.89 times |
| 28 Tue Apr 2026 | 2403.70 | 2327.30 to 2427.40 | 3.38% | 2.21 times |
| 27 Mon Apr 2026 | 2325.10 | 2290.90 to 2339.90 | 1.11% | 0.67 times |
| 24 Fri Apr 2026 | 2299.50 | 2283.20 to 2372.80 | -1.52% | 1.21 times |
| 23 Thu Apr 2026 | 2335.00 | 2212.10 to 2359.40 | 4.24% | 2.45 times |
| 22 Wed Apr 2026 | 2240.00 | 2204.80 to 2247.00 | 0.31% | 0.47 times |
| 21 Tue Apr 2026 | 2233.10 | 2215.20 to 2245.00 | 0.11% | 0.37 times |
| 20 Mon Apr 2026 | 2230.70 | 2210.50 to 2250.50 | -0.84% | 0.59 times |
| 17 Fri Apr 2026 | 2249.50 | 2240.90 to 2274.90 | 0% | 0.53 times |
| 16 Thu Apr 2026 | 2249.50 | 2228.60 to 2273.80 | -0.39% | 0.63 times |
| 15 Wed Apr 2026 | 2258.40 | 2205.00 to 2265.00 | 2.98% | 0.89 times |
Videos related to: GLENMARK NEWS why is Glenmark Pharmaceuticals Limited price falling or rising
Hindi Basics How To Trade In FnO Futures Options Stock Market
- NSE Screeners
- NSE Daily Screener
- NSE Weekly Screener
- NSE Monthly Screener
- Support & Resistance
- NSE Shares Near Support
- NSE Shares Near Resistance
